Genetic predisposition to celiac disease in Kazakhstan: Potential impact on the clinical practice in Central Asia

English version

Autoři: Dimitri Poddighe ^aff001; Aida Turganbekova ^aff002; Dana Baymukasheva ^aff002; Zhazira Saduakas ^aff002; Zhuldyz Zhanzakova ^aff002; Saniya Abdrakhmanova ^aff002
Působiště autorů: Department of Medicine, Nazarbayev University School of Medicine, Nur-Sultan City, Kazakhstan ^aff001; RSE on REM «Research and Production Center of Transfusion», Ministry of Health of the Republic of Kazakhstan, Nur-Sultan City, Kazakhstan ^aff002
Vyšlo v časopise: PLoS ONE 15(1)
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pone.0226546

Souhrn

Background

Celiac disease (CD) is a systemic immune-mediated disorder developing in HLA genetically predisposed individuals carrying HLA-DQ2 and/or HLA-DQ8 molecules. Recent evidences supported a predominant importance of HLA-DQB1 locus and, in particular, HLA-DQB1*02 alleles. This diagnosis is poorly considered in Kazakhstan, because of the assumption that CD is not prevalent in this population.

Objective

To demonstrate that the genetic predisposition to CD in Kazakhstan is not negligible and is actually comparable to Western populations.

Methods

Through the analysis of HLA-DQ genotypes of healthy bone marrow donors from Kazakhstan’s national registry, we estimated the HLA-related genetic predisposition to CD in the country.

Results

We demonstrated that the frequency of CD-related HLA-DQB1 alleles and, as a consequence, of predisposed individuals to CD in Kazakhstan is significant and comparable to countries with the highest disease prevalence.

Conclusion

Considering the dietary style in Kazakhstan, including wheat as a staple food, these results provided a preliminary background of knowledge to expect a significant CD prevalence in Kazakhstan and Central Asia by implementing appropriate and cost-effective diagnostic strategies.

Klíčová slova:

Wheat – Genetic loci – Diagnostic medicine – Asia – Epidemiology – Bone marrow – Genetic predisposition – Kazakhstan

Zdroje

1. Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018; 391(10115):70–81. doi: 10.1016/S0140-6736(17)31796-8 28760445

2. Lindfors K, Ciacci C, Kurppa K, Lundin KEA, Makharia GK, Mearin ML, Murray JA, Verdu EF, Kaukinen K. Coeliac disease. Nat Rev Dis Primers. 2019; 5(1):3. doi: 10.1038/s41572-018-0054-z 30631077

3. Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH,et al. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018; 16(6):823–836. doi: 10.1016/j.cgh.2017.06.037 29551598

4. Al-Hussaini A, Alharthi H, Osman A, Eltayeb-Elsheikh N, Chentoufi A. Genetic susceptibility for celiac disease is highly prevalent in the Saudi population. Saudi J Gastroenterol. 2018; 24(5):268–273. doi: 10.4103/sjg.SJG_551_17 29956690

5. Catassi C, Catassi GN. The puzzling relationship between human leukocyte antigen HLA genes and celiac disease. Saudi J Gastroenterol. 2018; 24(5):257–258. doi: 10.4103/sjg.SJG_388_18 30178779

6. Makharia GK, Catassi C. Celiac Disease in Asia. Gastroenterol Clin North Am. 2019; 48(1):101–113. doi: 10.1016/j.gtc.2018.09.007 30711203

7. Poddighe D, Rakhimzhanova M, Marchenko Y, Catassi C. Pediatric Celiac Disease in Central and East Asia: Current Knowledge and Prevalence. Medicina (Kaunas). 2019; 55(1). pii: E11.

8. Wilfinder WW, Mackey K, Chomczynski P. Effect of pH and ionic strength on the spectrophotometric assessment of nucleic acid purity. Biotechniques. 1997; 22(3):474–481. doi: 10.2144/97223st01 9067025

9. Blasczyk R. HLA diagnostic sequencing—conception, application and automation. Journal Lab Med 2003; 27 (9/10): 359–368.

10. Robinson J, Halliwell JA, Hayhurst JH, Flicek P, Parham P, Marsh SGE. The IPD and IPD-IMGT/HLA Database: allele variant databases Nucleic Acids Research (2015) 43:D423–431 doi: 10.1093/nar/gku1161 25414341

11. Rostami Nejad M, Rostami K, Emami M, Zali M, Malekzadeh R. Epidemiology of celiac disease in Iran: a review. Middle East J Dig Dis. 2011; 3(1):5–12. 25197526

12. Moore E, Grifoni A, Weiskopf D, Schulten V, Arlehamn CSL, Angelo M, et al. Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 496 adults from San Diego, California, USA. Hum Immunol. 2018; 79(12):821–822. doi: 10.1016/j.humimm.2018.09.008 30278218

13. Pietzak MM, Schofield TC, McGinniss MJ, Nakamura RM. Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles. Clin Gastroenterol Hepatol. 2009; 7(9):966–71. doi: 10.1016/j.cgh.2009.05.028 19500688

14. Megiorni F, Mora B, Bonamico M, Barbato M, Nenna R, Maiella G, et al. HLA-DQ and risk gradient for celiac disease. Hum Immunol. 2009; 70(1):55–59. doi: 10.1016/j.humimm.2008.10.018 19027045

15. Megiorni F, Pizzuti A. HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed Sci 2012; 19:88. doi: 10.1186/1423-0127-19-88 23050549

16. De Silvestri A, Capittini C, Poddighe D, Valsecchi C, Marseglia G, Tagliacarne SC, et al. HLA-DQ genetics in children with celiac disease: a meta-analysis suggesting a two-step genetic screening procedure starting with HLA-DQ β chains. Pediatr Res. 2018; 83(3):564–572. doi: 10.1038/pr.2017.307 29244800

17. Capittini C, De Silvestri A, Rebuffi C, Tinelli C, Poddighe D. Predominant Relevance of HLA-DQB1*02 allele in the genetic predisposition of children with Celiac Disease: further cues from a meta-analysis. Medicina (Kaunas) 2019; 55(5). pii:E190.

18. Poddighe D. Relevance of HLA-DQB1*02 allele in predisposing to Coeliac Disease. Int J Immunogenetics 2019; 46(4):274–275.

19. Poddighe D, Capittini C, Gaviglio I, Brambilla I, Marseglia GL. HLA-DQB1*02 allele in children with Celiac Disease: potential usefulness for targeted screening strategies. Int J Immunogenetics 2019; 46(5):342–345.

20. Poddighe D. Individual screening strategy for pediatric celiac disease. Eur J Pediatr. 2018; 177(12):1871. doi: 10.1007/s00431-018-3251-6 30225634

21. Kuranov AB, Kozhamkulov UA, Vavilov MN, Belova ES, Bismilda VL, Alenova AH, et al. HLA-class II alleles in patients with drug-resistant pulmonary tuberculosis in Kazakhstan. Tissue Antigens. 2014; 83(2):106–12. doi: 10.1111/tan.12279 24397488

22. Kuranov AB, Vavilov MN, Abildinova GZh, Akilzhanova AR, Iskakova AN, Zholdybayeva EV, et al. Polymorphisms of HLA-DRB1, -DQA1 and -DQB1 in inhabitants of Astana, the capital city of Kazakhstan. PLoS One. 2014; 9(12):e115265. doi: 10.1371/journal.pone.0115265 25531278